These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 28798862)

  • 1. Amiloride as a new RNA-binding scaffold with activity against HIV-1 TAR.
    Patwardhan NN; Ganser LR; Kapral GJ; Eubanks CS; Lee J; Sathyamoorthy B; Al-Hashimi HM; Hargrove AE
    Medchemcomm; 2017 May; 8(5):1022-1036. PubMed ID: 28798862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driving factors in amiloride recognition of HIV RNA targets.
    Patwardhan NN; Cai Z; Umuhire Juru A; Hargrove AE
    Org Biomol Chem; 2019 Oct; 17(42):9313-9320. PubMed ID: 31612165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Evolved RNA Recognition Motif That Suppresses HIV-1 Tat/TAR-Dependent Transcription.
    Crawford DW; Blakeley BD; Chen PH; Sherpa C; Le Grice SF; Laird-Offringa IA; McNaughton BR
    ACS Chem Biol; 2016 Aug; 11(8):2206-15. PubMed ID: 27253715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic peptides with a distinct arginine-fork motif recognize the HIV trans-activation response RNA in vitro and in cells.
    Chavali SS; Mali SM; Bonn R; Saseendran Anitha A; Bennett RP; Smith HC; Fasan R; Wedekind JE
    J Biol Chem; 2021 Dec; 297(6):101390. PubMed ID: 34767799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors.
    Chavali SS; Mali SM; Jenkins JL; Fasan R; Wedekind JE
    J Biol Chem; 2020 Dec; 295(49):16470-16486. PubMed ID: 33051202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition of HIV TAR RNA by triazole linked neomycin dimers.
    Kumar S; Arya DP
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4788-92. PubMed ID: 21757341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal-Enhanced Aggregation-Induced Emission Strategy for the HIV-I RNA-Binding Ligand Assay.
    Li J; Fan YY; Wen J; Zhang J; Zhang ZQ
    Anal Chem; 2022 Mar; 94(11):4695-4702. PubMed ID: 35258935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA.
    Abulwerdi FA; Shortridge MD; Sztuba-Solinska J; Wilson R; Le Grice SF; Varani G; Schneekloth JS
    J Med Chem; 2016 Dec; 59(24):11148-11160. PubMed ID: 28002966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of HIV-1 TAR RNA-ligand complexes.
    Mitrasinovic PM; Tomar JS; Nair MS; Barthwal R
    Med Chem; 2011 Jul; 7(4):301-8. PubMed ID: 21574948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA.
    Bradrick TD; Marino JP
    RNA; 2004 Sep; 10(9):1459-68. PubMed ID: 15273324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivalency in the recognition and antagonism of a HIV TAR RNA-TAT assembly using an aminoglycoside benzimidazole scaffold.
    Kumar S; Ranjan N; Kellish P; Gong C; Watkins D; Arya DP
    Org Biomol Chem; 2016 Feb; 14(6):2052-6. PubMed ID: 26765486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.
    Xie B; Calabro V; Wainberg MA; Frankel AD
    J Virol; 2004 Feb; 78(3):1456-63. PubMed ID: 14722301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of HIV TAR in complex with a Lab-Evolved RRM provides insight into duplex RNA recognition and synthesis of a constrained peptide that impairs transcription.
    Belashov IA; Crawford DW; Cavender CE; Dai P; Beardslee PC; Mathews DH; Pentelute BL; McNaughton BR; Wedekind JE
    Nucleic Acids Res; 2018 Jul; 46(13):6401-6415. PubMed ID: 29961805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-RNA interaction assay based on size-selective fluorescence core-shell nanocomposite.
    Li J; Wang M; Fan YY; Duan HL; Deng X; Zhang ZQ
    Anal Bioanal Chem; 2020 Oct; 412(26):7349-7356. PubMed ID: 32783126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a small molecule Tat-trans-activation-responsive RNA antagonist that potently inhibits human immunodeficiency virus-1 replication.
    Hwang S; Tamilarasu N; Kibler K; Cao H; Ali A; Ping YH; Jeang KT; Rana TM
    J Biol Chem; 2003 Oct; 278(40):39092-103. PubMed ID: 12857725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
    Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
    Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering structure-activity relationships in a series of Tat/TAR inhibitors.
    Pascale L; González AL; Di Giorgio A; Gaysinski M; Teixido Closa J; Tejedor RE; Azoulay S; Patino N
    J Biomol Struct Dyn; 2016 Nov; 34(11):2327-38. PubMed ID: 26524629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
    Chavali SS; Bonn-Breach R; Wedekind JE
    J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based computational database screening, in vitro assay, and NMR assessment of compounds that target TAR RNA.
    Lind KE; Du Z; Fujinaga K; Peterlin BM; James TL
    Chem Biol; 2002 Feb; 9(2):185-93. PubMed ID: 11880033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design-Based Peptidomimetic Ligand Discovery to Target HIV TAR RNA Using Comparative Analysis of Different Docking Methods.
    Fu J; Xia A; Dai Y; Qi X
    Curr HIV Res; 2016; 14(6):476-483. PubMed ID: 27450546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.